Cellular Immunotherapy in Septic Shock: A Meeting to Develop a Stem Cell in Sepsis International Collaborative Network

感染性休克的细胞免疫疗法：开发脓毒症干细胞的会议国际合作网络

• 批准号: 372833
• 负责人: McIntyre Lauralyn A
• 金额: $ 0.73万
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Miscellaneous Programs
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-08-01 至 2018-08-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=372833&lang=en
• 关键词: Biological Data; International Meeting; Mesenchymal Stem Cells; Mesenchymal Stromal Cells; Network; Randomized Controlled Trial; Septic Shock

Severe infection with shock (septic shock) in the intensive care unit (ICU) is common accounting for approximately 20% of admissions, of which 20-40% will die. Septic shock is associated with an immensely uncontrolled inflammatory response from the body t

重症监护病房(ICU)的重症感染合并休克(感染性休克)是常见的，约占入院人数的20%，其中20%-40%将死亡。感染性休克与机体过度失控的炎症反应有关。